Description
Afatinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that has certain types of abnormal epidermal growth factor receptor (EGFR) genes in patients.
afatinib tablets is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: • has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you. • has spread to other parts of the body (metastatic), and • has not been previously treated for metastatic lung cancer It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes. or is used to treat people with squamous cell lung cancer that: • has spread to other parts of the body, and has been previously treated with chemotherapy that contains platinum. It is not known if GILOTRIF is safe and effective in children.
Active ingredient: afatinib Inactive ingredients: Tablet Core: lactose monohydrate, microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate. Tablet Coating: hypromellose, polyethylene glycol, titanium dioxide, talc, polysorbate 80, FD&C Blue No. 2 (40 mg and 30 mg tablets only).
How can 1 go about obtaining afatinib tablets?
If afatinib tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).